EMERYVILLE, Calif., Jan. 6, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing...
Conference
Nearly two decades ago, a passionate group of Yale students and alumni launched a new conference aimed at gathering thinkers...
